文献速递肺血管病与心包/心肌炎心力衰竭与心肌病

心脏肌成纤维细胞在右心室衰竭中的关键作用及UCP2单核苷酸多态性对PAH右室失代偿易感性的影响

Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
PubMed 文献 · Circulation · 2026-03-09

该研究探讨心脏肌成纤维细胞(cMFBs)在肺动脉高压(PAH)右心室由代偿向失代偿转变中的作用,以及UCP2功能缺失性单核苷酸多态性(rs659366)与右室失代偿的关联。研究采用两种大鼠模型(野百合碱MCT与肺动脉环缩PAB)及三个PAH与第二组肺高血压(PHT-2)患者队列(n=81)。结果显示cMFBs增加是右室失代偿的驱动因素,TNF-α或rs659366可能作为PAH早期右室失代偿的生物标志物。

要点

  • 右室心脏肌成纤维细胞(cMFBs)转化是右室失代偿的关键驱动因素。
  • TNF-α下调右室成纤维细胞UCP2,且rs659366与右室功能恶化相关。
  • UCP2水平降低和rs659366可作为PAH早期右室失代偿的潜在生物标志物。

核心结论

  • 右室心脏成纤维细胞向肌成纤维细胞的身份转变是右室失代偿的驱动因素。
  • TNF-α或rs659366是PAH早期右室失代偿的潜在生物标志物。

研究设计与样本

  • 研究使用两种大鼠模型:野百合碱(MCT)模型与炎症较轻的肺动脉环缩(PAB)模型。
  • 研究纳入三个患者队列(n=81),比较PAH与第二组肺高血压(PHT-2)。

主要发现

  • MCT大鼠右室cMFBs显著增加,而PAB右室未见显著增加,且PAB右室失代偿远晚于MCT右室。
  • 离体心脏中MCT失代偿右室收缩力降低,但离体心肌细胞未降低,提示非心肌细胞原因。
  • MCT失代偿右室cMFBs线粒体呼吸低于对照和代偿右室cFBs,而MCT右室心肌细胞线粒体呼吸增加。
  • 从正常到MCT代偿右室再到失代偿右室cMFBs,mCa++进行性降低,c(M)FBs的UCP2也呈相同趋势,但心肌细胞无此变化。
  • TNF-α降低右室cFBs的UCP2 mRNA/蛋白水平,但不降低右室心肌细胞。

临床怎么用

  • 在PAH患者中,可关注右室cMFBs转化及UCP2水平作为右室失代偿的评估指标。
  • rs659366基因分型可能有助于识别右室失代偿风险较高的PAH患者。
  • TNF-α介导的UCP2下调可能成为干预右室失代偿的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to decompensated RV (dRV) is unknown, and some PAH patients develop dRV faster than others. METHODS: We explored the role of RV cardiac myofibroblasts (cMFBs) on this transition utilizing 2 rat models: monocrotaline (MCT) versus the less inflammatory pulmonary artery banding (PAB); and 3 patient cohorts (n=81) of PAH versus group 2 pulmonary hypertension (PHT-2). We hypothesized that loss of UCP2 (uncoupling protein 2), critical for mitochondrial calcium (mCa++) regulation and cardiac fibroblasts (cFBs) differentiation to cMFBs, is associated with dRV; and that a loss-of-function UCP2 single nucleotide polymorphism (SNP; rs659366) may predict dRV in human PAH. RESULTS: We separated rat cRV from dRV based on catheterization and echocardiographic criteria and found a significant increase in cMFBs from MCT but not PAB RV (which decompensated much later than MCT RV). In isolated hearts, MCT RV contractility was lower in dRV but not in isolated cardiomyocytes (CMs), pointing to a non-CM cause. Mitochondrial respiration was lower in MCT dRV cMFBs than in control and cRV cFBs but increased in MCT-RV CMs. mCa++ was progressively decreased from normal to MCT-cRV to dRV cMFBs, and the same was true for c(M)FBs (but not CMs) UCP2. Tumor necrosis factor alpha (TNF-α) decreased UCP2 mRNA/protein levels in RV cFBs but not RV CMs. In human PAH, but not PHT-2, dRVs had more cMFBs and less UCP2 than control and cRVs. Decreased UCP2 levels and rs659366 were associated with worse RV performance (tricuspid annular plane systolic excursion and cardiac index), even among patients with similar mean pulmonary arterial pressure. CONCLUSIONS: Our data suggest that a change of cell identity (cFBs to cMFBs) in the RV is a driver of RV decompensation. TNF-α or rs659366 is a potential biomarker for early RV decompensation in PAH.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Bonnet S, Provencher S, et al. Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension. Circulation. 2026. PMID: 41797703. doi:10.1161/CIRCULATIONAHA.125.078674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。